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RESEARCH ARTICLE
Depletion of regulatory T cells leads to an exacerbation of delayed-
type hypersensitivity arthritis in C57BL/6 mice that can be
counteracted by IL-17 blockade
Sara Marie Atkinson1,2,‡,¶, Ute Hoffmann3, Alf Hamann3, Emil Bach4, Niels Banhos Danneskiold-Samsøe4,
Karsten Kristiansen4, Kyle Serikawa5,*, Brian Fox6,‡, Kim Kruse1, Claus Haase1, Søren Skov2 and
Anneline Nansen7,§
ABSTRACT
Rodent models of arthritis have been extensively used in the
elucidation of rheumatoid arthritis (RA) pathogenesis and are
instrumental in the development of therapeutic strategies. Here we
utilise delayed-type hypersensitivity arthritis (DTHA), a model in
C57BL/6 mice affecting one paw with synchronised onset, 100%
penetrance and low variation. We investigate the role of regulatory T
cells (Tregs) in DTHA through selective depletion of Tregs and the role
of IL-17 in connection with Treg depletion. Given the relevance of Tregs
in RA, and the possibility of developing Treg-directed therapies, this
approach could be relevant for advancing the understanding of Tregs
in inflammatory arthritis. Selective depletion of Tregs was achieved
using a Foxp3-DTR-eGFP mouse, which expresses the diphtheria
toxin receptor (DTR) and enhanced green fluorescent protein (eGFP)
under control of the Foxp3 gene. Anti-IL-17 monoclonal antibody
(mAb) was used for IL-17 blockade. Numbers and activation of
Tregs increased in the paw and its draining lymph node in DTHA,
and depletion of Tregs resulted in exacerbation of disease as shown
by increased paw swelling, increased infiltration of inflammatory
cells, increased bone remodelling and increased production of
inflammatory mediators, as well as increased production of
anti-citrullinated protein antibodies. Anti-IL-17 mAb treatment
demonstrated that IL-17 is important for disease severity in both the
presence and absence of Tregs, and that IL-17 blockade is able to
rescue mice from the exacerbated disease caused by Treg depletion
and caused a reduction in RANKL, IL-6 and the number of
neutrophils. We show that Tregs are important for the containment of
inflammation and bone remodelling in DTHA. To our knowledge, this
is the first study using the Foxp3-DTR-eGFP mouse on a C57BL/6
background for Treg depletion in an arthritis model, and we here
demonstrate the usefulness of the approach to study the role of Tregs
and IL-17 in arthritis.
KEY WORDS: Rheumatoid arthritis, Regulatory T cells, IL-17,
Neutrophils, C57BL/6, ACPA, Microbiota
INTRODUCTION
Rodent models of arthritis have been extensively used in the process
of elucidating the pathogenesis of rheumatoid arthritis (RA), a
chronic inflammatory disease characterised by chronic joint
inflammation and bone erosion, and they are instrumental in the
development of new therapeutic strategies (Asquith et al., 2009).
Delayed-type hypersensitivity arthritis (DTHA) is an arthritis model
in C57BL/6 (B6) mice that is characterised by synchronised
onset, 100% penetrance and low variation. DTHA is induced by
modifying a protein-antigen-induced delayed-type hypersensitivity
response in the paw by administration of an anti-type-II-collagen
antibody cocktail (anti-CII) between immunisation and challenge.
The result is severe inflammatory arthritis affecting one, pre-
defined, hind paw (Atkinson et al., 2012). Notably, the anti-CII dose
required for DTHA is five- to eight-times lower than required for
induction of collagen-antibody-induced arthritis (CAIA) in B6 mice
(Hutamekalin et al., 2009).
Owing to their well-established role in controlling inflammation
in many animal models, we hypothesise that regulatory T cells
(Tregs) play a role in the resolution of inflammation in DTHA. It has
been shown in mouse models of arthritis that deficiency or depletion
of Tregs exacerbates disease, and increasing numbers of Tregs can
reduce disease activity (Gizinski and Fox, 2014; Kelchtermans
et al., 2009; Miyara et al., 2014; Noack and Miossec, 2014; Zaiss
et al., 2010). The development of a more sustained disease
phenotype in the absence of Tregs would let us study disease
drivers unchecked by this immunoregulatory cell subset and to
identify which disease driver mechanisms are suppressed by Tregs
in vivo in experimental arthritis. The purpose of the present study
was therefore to investigate the mechanisms of self-limiting disease
in DTHA through selective depletion of Tregs after disease
induction. Treg depletion studies in experimental arthritis models
are scant and have mainly used the anti-CD25 approach. Anti-CD25
treatment in collagen-induced arthritis (CIA) accelerates disease
(Kelchtermans et al., 2005; Morgan et al., 2003). Administration of
anti-CD25 prior to induction exacerbates glucose-6-phospate
isomerase (G6PI)-induced arthritis (Frey et al., 2010) and antigen-
induced arthritis (AIA) (Frey et al., 2005). However, using anti-
CD25 antibodies for depletion of Tregs also targets effector T cells
(Teff ). The Foxp3-DTR-eGFP mouse allows selective depletion ofReceived 21 August 2015; Accepted 22 January 2016
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Tregs without affecting Teff. This mouse expresses a fusion of a
diphtheria toxin receptor (DTR) and enhanced green fluorescent
protein (eGFP) under the control of the forkhead box protein 3
(Foxp3) gene locus, which means that Tregs can be selectively
depleted by administration of diphtheria toxin (DT) (Feuerer et al.,
2009; Lahl et al., 2007). Treg depletion in Foxp3-DTR-eGFP mice
on a DBA/1 background exacerbated G6PI-induced arthritis (Irmler
et al., 2014). However, to our knowledge, this is the first study to
address, in-depth, the use of the Foxp3-DTRe-GFP mouse for Treg
depletion in experimental arthritis and the first to use the Foxp3-
DTR-eGFP mouse on a B6 background in experimental arthritis.
RA has recently been associated with changes in the gut
microbiota (Scher et al., 2013; Zhang et al., 2015). In spontaneous
mouse models of autoimmune arthritis, joint inflammation is
attenuated under germ-free conditions, but colonisation of the gut
with commensal microbes is sufficient to elicit joint inflammation
comparable to that observed in conventional mice (Abdollahi-
Roodsaz et al., 2008; Wu et al., 2010). In these models, the
colonisation of the gut resulted in a perturbed Treg/Teff balance,
which was associated with disease onset and progression. The
interplay between Tregs and the gut microbiota modulates Treg
abundance and function and might thereby also affect onset and
progression of arthritis. Therefore, we also analysed the fecal
microbiota following DTHA induction alone and in conjunction
with Treg depletion.
In the present study, we found that depleting Tregs after onset of
DTHA led to an exacerbation of arthritis. Inflammatory cell
infiltration, osteoclast activation and bone erosion were increased
in Treg-depleted mice. Treg depletion also increased levels of anti-
mutated-citrullinated-vimentin (MCV) antibodies, indicating an
increase in autoimmunity associated with increased protein
citrullination. Production of a wide range of cytokines and
chemokines was increased, including IL-17, a cytokine involved
in the pathogenesis of both RA and murine experimental arthritis.
We show that treating Treg-depleted mice with anti-IL-17
monoclonal antibody (mAb) rescues them from exacerbation of
disease through a reduction of circulating neutrophils and a reduction
in IL-6 and receptor-activator of nuclear factor κB ligand (RANKL).
RESULTS
A highly activated and proliferating subset of Tregs is found in
the lymph node draining the arthritic paw early after disease
onset
We investigated the dynamics of Tregs in DTHA by analysing the
popliteal lymph node draining the arthritic paw (dPLN), the
popliteal lymph node draining the control paw (ndPLN), paw
infiltrate and blood at different time points during disease by
flow cytometry (Fig. 1A). Tregs were defined as live
CD45+TCRβ+CD4+CD25+FoxP3+ cells and Teff cells by inverting
the CD25+FoxP3+ gate within the CD45+TCRβ+CD4+ gate (full
gating strategy shown in Fig. S1A). Tregs were most abundant in the
dPLN on day 2 and 4 after DTHA induction and were still elevated
compared to day 1 and naïve mice on day 7. The increase in Treg
number in the dPLN was also reflected in blood (Fig. 1B). A
dramatic increase in activated (CD44+) and proliferating (Ki67+)
Tregs was seen in the dPLN, but not in the ndPLN or in blood
(Fig. 1B, bottom graphs). Analysis of Foxp3 mRNA showed a
significantly higher Foxp3 expression in paws on day 3 and 8
compared to before arthritis induction (Fig. 1C). The same was
seen with Ctla4 mRNA, which codes for the surface marker
cytotoxic T-lymphocyte-associated protein 4 (CTLA4) found on
Tregs and memory T cells, but to a greater extent on Tregs (Jago et al.,
2004) (Fig. 1C). No increase in Treg numbers in blood or popliteal
lymph nodes was observed during the immunisation phase of
DTHA (from naïve to day 0), so we also analysed the inguinal
lymph nodes (ILNs), which drain the immunisation sites, in naïve
mice and immediately prior to methylated bovine serum albumin
(mBSA) challenge. In these lymph nodes a dramatic increase in the
frequency of both Treg and Teff cells was observed (Fig. 1D), but
this increase was not reflected in the number of circulating Tregs or
Teff on day 0 (Fig. 1B). Interestingly, a subpopulation of
CD25hiFoxP3hi Tregs was found in the dPLN but not in the ndPLN
or blood (Fig. 1E,F). These CD25hiFoxP3hi Tregs were found to
possess an activated phenotype and were actively proliferating
already fromday 1 post-DTHA induction (Fig. 1G).We also analysed
cells isolated from the arthritic paw on day 2 and 4 after DTHA
induction and found the fraction of Tregs of total T cells to increase
from 12.17±1.09% to 14.70±0.63% from day 2 to 4 (mean±s.e.m.,
P=0.079, Student’s t-test). Analysis of immune cells isolated from
non-inflamed paws is not feasible owing to the very low number of
cells that it is possible to harvest. We also found subpopulations of
CD25hiFoxP3hi and Ki67+ Tregs in the paw. Among paw infiltrating
T cells on day 2 and day 4, we found 33.72±4.16% and 23.04±1.55%
of Tregs to be CD25
hiFoxP3hi (mean±s.e.m., P=0.044, Student’s
t-test) and 82.16±1.3% and 86.35±1.2% of Tregs to be Ki67
+
(mean±s.e.m., P=0.034, Student’s t-test), respectively. In summary,
we observed increased numbers of activated and proliferating Tregs in
the dPLN and paw early after mBSA challenge in DTHA.
Depletion of Tregs after arthritis induction exacerbates
inflammation and leads to a rapid increase in arthritic
disease activity
In order to assess the importance of Tregs in regulating DTHA
severity, we selectively depleted Tregs by administration of DT at 24
and 48 h after arthritis induction to Foxp3-DTR-eGFP mice
(FoxP3-DTR+) and littermate controls (FoxP3-DTR−). This
resulted in depletion of all eGFP+ cells in FoxP3-DTR+ mice as
confirmed by flow cytometry (Fig. S2). However, eGFP+ cells
eventually repopulate the Treg niche after transient DT treatment, as
shown in Fig. S2C. Depletion of Tregs rapidly led to increased paw
and ankle swelling, which persisted up to at least day 10
(Fig. 2A,B). In Treg-depleted mice, levels of the acute-phase
protein serum amyloid P component (SAP) were elevated in serum
on day 10 compared to control mice (Fig. 2C), as was C-terminal
telopeptide of type I collagen (CTX-I; Fig. 2D), whereas tartrate-
resistant acid phosphatase (TRAP) serum levels were not increased
(Fig. 2D). Histopathological analysis on day 10 showed increased
infiltration of macrophages into the Treg-depleted paws (Fig. 2E,F).
Histological scoring revealed a tendency towards increased bone
erosion in Treg-depleted mice, whereas there was no difference in
cartilage degradation and synovitis (Fig. 2G). However,
inflammation and new bone formation at extra-articular sites were
increased in Treg-depleted mice, and so was the histopathological
sum score (Fig. 2H). Interestingly, we observed a correlation
(r=0.5949, P=0.0092, n=18) between extra-articular inflammation
and new bone formation (Fig. 2I), indicating that new bone
formation in DTHA is an inflammation-associated process.
Depletion of Tregs leads to an increase in biomarkers of
arthritis and inflammatory cells in the affected paw and in
circulation
Next, we investigated the mechanisms of the increased arthritis
response following Treg depletion by sampling on day 4 and 7
post-arthritis induction. We found increased paw swelling in Treg-
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depleted mice (Fig. 3A), and increased levels of SAP, IL-6 and
matrix metalloproteinase 3 (MMP3) on both day 4 and 7 in Treg-
depleted mice (Fig. 3B). Levels of CTX-I were increased on day 7
but not day 4. Neutrophil chemoattractant granulocyte colony
stimulating factor (G-CSF) was increased on day 4, but not day 7
(Fig. 3B). Interestingly, we detected production of anti-MCV in
DTHA, and, following Treg depletion, anti-MCV antibody levels
were increased in serum (Fig. 3B). In order to investigate whether
Tregs play a role in regulating bone resorption in DTHA, we
measured levels of RANKL, osteoprotegerin (OPG) and TRAP in
whole paw tissue. We found that levels of both RANKL and TRAP
increased in the arthritic paws on day 4 and 7, and the RANKL/OPG
ratio increased after Treg depletion (Fig. 3C). We also investigated
the cellular players in the increased inflammatory response
after Treg depletion. Systemic neutrophilia and increased numbers
of neutrophils in inflamed paws and dPLNs were observed
Fig. 1. Dynamics and phenotypic characterisation of regulatory T cells (Tregs) during delayed-type hypersensitivity arthritis (DTHA). (A) DTHA was
induced by immunising mice with methylated bovine serum albumin (mBSA) emulsified in complete Freund’s adjuvant (CFA) on day −7, followed by an
intravenous (i.v.) dose of an anti-type-II-collagen antibody cocktail (anti-CII) on day −3. On day 0 the mice were challenged with mBSA in the right hind paw and
with vehicle in the left hind paw. Δpaw swelling on day x was calculated by subtracting the baseline measurement made on day 0 prior to challenge from the
measurement made on day x. n=5-35; mean±s.d. shown. (B) Tregs were defined as live CD45
+TCRβ+CD4+CD25+FoxP3+ cells, and effector T cells (Teff ) by
inverting the CD25+FoxP3+ gate within the CD45+TCRβ+CD4+ gate. Tregs were further gated on the activation marker CD44 and the proliferation marker Ki67.
Total numbers of Tregs, Teff, CD44
+ Tregs and Ki67
+ Tregs are shown in blood (cells/ml), the popliteal lymph node draining the arthritic paw (dPLN) and the popliteal
lymph node draining the control paw (ndPLN). Mean±s.e.m. is shown, n=5. (C) Foxp3 and Ctla4mRNA in arthritic paws measured by mRNA deep sequencing.
RPKM, reads per kilobase of transcript per million mapped reads. Mean shown, n=4. **P≤0.01, ***P≤0.001, difference to levels on day 0, one-way ANOVA.
(D) Total cell counts in the inguinal lymph nodes. Tregs were defined as live CD45
+TCRβ+CD4+CD25+FoxP3+ cells and Teff by inverting the CD25
+FoxP3+ gate
within the CD45+TCRβ+CD4+ gate, n=6, mean±s.e.m. shown. Student’s t-test, ***P≤0.001. (E) Representative flow cytometry plots from day 2 post-DTHA
induction showing CD25hiFoxP3hi Treg populations (box) in dPLN, ndPLN and blood. Cells were defined as live CD45
+TCRβ+CD4+ before gating on CD25 and
FoxP3. The top panel shows FoxP3 staining and the bottom panel staining with IgG2a isotype control antibody. (F) Percentage of CD25hiFoxP3hi Tregs in dPLN,
ndPLN and blood after induction of DTHA and in naïve mice. Mean±s.e.m. shown, n=3-6. Difference to percentages in naïve mice analysed using one-way
ANOVA, **P≤0.01, ***P≤0.001. (G) Percentage of CD25hiFoxP3hi Tregs in dPLN expressing CD44 (left) and Ki67 (right); mean±s.d. shown, n=3-6. All
experiments presented in this figure were carried out once. Full flow cytometry gating strategy is shown in Fig. S1A.
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(Fig. 4A,B). Increased numbers of macrophages in the inflamed
paws and dPLNs were also observed (Fig. 4B and data not shown).
Numbers of CD4+ T cells in the paw were increased compared to
controls on day 7 but not day 4 (Fig. 4B), but there was no increase
in CD4+ T cells in the dPLN (Fig. 4C). However, CD4+ T cells in
the dPLN were found to be more activated (Fig. 4D). Taken
together, these data show that depletion of Tregs increases systemic
inflammation, increases the production of autoantibodies, increases
bone resorption, increases the numbers of neutrophils and
macrophages in the inflamed paw and its draining lymph node,
and enhances T-cell activation.
Concomitant depletion of Tregs and blockade of IL-10
signalling increased paw and ankle swelling to an even
larger degree than Treg depletion or IL-10 blockade alone
We found that concomitant depletion of Tregs and blockade of IL-10
signalling increased paw and ankle swelling to an even larger degree
than Treg depletion or IL-10 blockade alone (Fig. S3A-C). Active
Fig. 2. Depletion of Tregs leads to increased disease activity in DTHA. Tregs were depleted frommice carrying the Foxp3-DTR-eGFP transgene (FoxP3-DTR
+)
by administration of diphtheria toxin (DT) 24 and 48 h after DTHA induction. Non-transgene littermates (FoxP3-DTR−) were used as controls and also given DT.
Paw and ankle swelling shown over the duration of the study (A) and as area under curve (AUC) (B), n=8-10, mean±s.e.m. shown. Student’s t-test, *P≤0.05;
**P≤0.01; ***P≤0.001. (C) Serum levels of serum amyloid P component (SAP) in serummeasured 10 days after DTHA induction by ELISA, n=8-10, mean±s.e.m.
shown. Student’s t-test, **P≤0.01. (D) Serum levels of C-terminal telopeptide of type I collagen (CTX-I) and tartrate-resistant acid phosphatase (TRAP) measured
10 days after DTHA induction by ELISA, n=8-10, mean±s.e.m. shown. Student’s t-test, *P≤0.05. (E) Representative images of immunohistochemistry (IHC)
stainings for the macrophage marker F4/80 or the neutrophil marker Ly6B.2. Positively stained cells appear brown. Scale bars: 1 mm. (F) Macrophage and
neutrophil infiltration quantified by analysing paw sections stained by immunohistochemistry for the macrophage marker F4/80 or the neutrophil marker Ly6B.2
using digitalised image analysis software. Target-cell infiltration was defined as percentage of 3-3′-diamino-benzidine-tetrahydrochloride-positive (DAB+) area of
total paw area. n=8-10, mean±s.e.m. shown. Student’s t-test, **P≤0.01. (G) Semi-quantitative histopathological scoring of arthritic and inflammatory parameters
on day 10 using a scale of 0-3 (see Materials and Methods for details), n=8-10, mean±s.e.m. shown. Student’s t-test with Welch’s correction, *P≤0.05; **P≤0.01.
(H) Sum of the individual scores in G. Maximum possible score is 15. n=8-10, mean±s.e.m. shown. Student’s t-test with Welch’s correction, *P≤0.05.
(I) Correlation between the histopathological scores for extra-articular inflammation and bone formation in all mice. Slope±95% CI shown, n=18 (some points are
on top of each other). Spearman r=0.5949, P=0.0092. Results presented in this figure are representative of two independent experiments.
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bone remodelling on day 10 post-arthritis induction, measured
through serum CTX-I, was only detectable in mice with both
depleted Tregs and blocked IL-10R signalling (Fig. S3D).
Depletion of Tregs increases bacterial diversity transiently
without affecting the overall major taxonomic composition
of fecal microbiota
Fecal samples from the distal colon were collected before DTHA
induction on day 0, and on day 4 and 9 following DTHA induction
with or without concurrent depletion of Tregs. The composition of
the microbiota was investigated by sequencing of the V4
hypervariable region of the 16S rRNA gene. Principal coordinate
analysis (PCoA) at the level of operational taxonomic units (OTUs)
revealed no significant changes in overall clustering following
DTHA induction (Fig. S4). However, we found that the bacterial
composition of the Treg-depleted mice was more diverse on day 4
compared to the non-depleted mice (Fig. 5A), with a tendency
towards an increase in alpha diversity for the Treg-depleted mice
from day 0 to 4 (P=0.141), whereas beta diversity did not differ
significantly (Fig. 5B). Interestingly, alpha diversity correlated
inversely with ankle swelling for the Treg-depleted group at day 4
(Spearman’s ρ=−0.964; P<0.01; n=7). Analysis at the phylum level
revealed no significant differences between the two groups, or
between days within each group (Fig. 5C). We detected no
significant changes in the relative abundance of genera (Fig. 5D)
between groups, or between days within each group, although the
abundance of Lactobacillus tended to be higher on day 4 compared
to day 0 and 9 (P=0.084 and 0.12 for FoxP3-DTR+ and P=0.229
and 0.305 for FoxP3-DTR−, respectively). Correlations between
taxa abundance and ankle swelling, paw swelling, TRAP, and
CTX-I, respectively, did not show high correlation coefficients or
patterns of correlations (data not shown). Taken together, these data
show that DTHA induction alone or in conjunction with the
depletion of Tregs induce only minor and transient compositional
changes in the fecal bacterial microbiota. Thus, contrasting with
results obtained by analysis of RA patients (Zhang et al., 2015), no
significant arthritis-associated changes in the gut microbiota were
detected in the mouse models.
Fig. 3. Depletion of Tregs leads to rapidly increased inflammatory and arthritic activity both locally and systemically. (A) Tregs were depleted from mice
carrying the Foxp3-DTR-eGFP transgene (FoxP3-DTR+) by administration of diphtheria toxin (DT) 24 and 48 h after DTHA induction. Non-transgene littermates
(FoxP3-DTR−) were used as controls. Paw swelling shown over the duration of the study (left) and as paw weight (right). Mean±s.e.m. shown, n=10. Student’s
t-test, *P≤0.05; ***P≤0.001. (B) Serum levels of matrix metalloproteinase 3 (MMP3), C-terminal telopeptide of type I collagen (CTX-I), IL-6, antibodies to mutated
citrullinated vimentin (anti-MCV), granulocyte colony stimulating factor (G-CSF) and serum amyloid P component (SAP) were measured by ELISA in serum
on day 4 and 7 post-DTHA induction. Mean±s.e.m. shown, n=10. Student’s t-test, *P≤0.05; **P≤0.01; ***P≤0.001. (C) Levels of receptor-activator of nuclear
factor kappa B ligand (RANKL), osteoprotegerin (OPG) and tartrate-resistant acid phosphatase (TRAP) were measured by ELISA in whole paw homogenate
supernatants on day 4 and 7 after DTHA induction. Mean±s.e.m. shown, n=10. Student’s t-test, *P≤0.05; **P≤0.01; ***P≤0.001. Dotted line represents mean
OPG level in n=2 naïve mice. Results presented in this figure are representative of two independent experiments.
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Depletion of Tregs leads to increased production of
inflammatory mediators locally in the arthritic paws
To further elucidate the mechanisms of increased inflammation
following Treg depletion in DTHA, we measured levels of a range of
cytokines and chemokines in whole paw tissue. The cytokines IL1β,
IL-17, IL-12(p70), IL-6 and IL-10 were all increased in paw tissue
on both day 4 and 7 compared with controls (Fig. 6). IFNγ was
increased only on day 4 and TNFα only on day 7 (Fig. 6). The
chemokines CCL2 (MCP-1), CXCL10 (IP-10), CXCL5 (LIX),
CCL5 (RANTES) and CXCL9 (MIG) were all increased in paw
tissue on both day 4 and 7 compared with controls (Fig. 6). CXCL2
(MIP-2), CCL3 (MIP-1α) and CXCL1 (KC) were increased only on
day 7 and tended to increase on day 4 (Fig. 6). Levels of G-CSF
were increased in paw tissue on day 7 and tended to increase on
day 4 (Fig. 6). Granulocyte-macrophage colony-stimulating factor
(GM-CSF) was increased in paw tissue both on day 4 and 7 after
DTHA induction (Fig. 6). Taken together, these data show a profile
of inflammatory mediators that both favours and is a result of Th17
T-cell polarisation, T-cell infiltration and activation, and neutrophil
and macrophage infiltration and activation.
Treatment with anti-IL-17 mAb rescues mice from
exacerbation of disease caused by depletion of Tregs
Based on our findings so far, we hypothesised that IL-17 could play
a part in the increased disease activity observed following Treg
depletion. To test this, we set up a study where Treg-depleted mice
were also treated with anti-IL-17 mAb. We found that anti-IL-17
treatment reduced paw swelling in mice both with and without intact
Treg compartments (Fig. 7A). We also found that anti-IL-17
treatment of Treg-depleted mice reduced paw swelling to levels
seen in isotype-treated, non-Treg-depleted mice, thus rescuing them
from the exacerbated disease caused by the depletion of Tregs
Fig. 4. Treg depletion in DTHA leads to increased neutrophil recruitment and CD4
+ T-cell activity. (A) Counts and percentages of neutrophils were analysed
in blood and the popliteal lymph node draining the arthritic paw (dPLN) on day 4 and 7 after DTHA induction by flow cytometry. Neutrophils were defined as live
CD45+CD11b+Ly6G+. Mean±s.e.m. shown, n=10. Student’s t-test, *P≤0.05; **P≤0.01. (B) Cell counts of total live cells, CD4+ T cells, macrophages and
neutrophils in the arthritic paw analysed on day 4 and 7 after DTHA induction by flow cytometry. CD4+ T cells and neutrophils defined as before, macrophages
defined as live CD45+CD11b+F4/80+ cells. Mean±s.e.m. shown, n=10. Student’s t-test, *P≤0.05; **P≤0.01; ***P≤0.001. (C) Counts and percentages of CD4+
T cells analysed in the dPLN on day 4 and 7 after DTHA induction by flow cytometry. CD4+ T cells were defined as live CD45+TCRβ+CD4+ cells. Mean±s.e.m.
shown, n=10. Student’s t-test, **P≤0.01. (D) Median fluorescence intensity (MFI) of CD44-APC (left) and CD62L-PE (right) in the CD4+ T-cell gate. Mean±s.e.m.
shown, n=10. Student’s t-test, **P≤0.01; ***P≤0.001. Results presented in this figure are representative of two independent experiments. Full flow cytometry
gating strategy is shown in Fig. S1B,C.
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(Fig. 7A). Starting anti-IL-17 treatment at immunisation (Fig. S5)
did not reduce paw swelling to a greater degree than anti-IL-17
treatment begun at the time of arthritis induction (Fig. 7A). Anti-IL-
17 treatment did not have an effect on the production of anti-MCV
(Fig. 7B). There was a tendency towards reduced myeloperoxidase
(MPO) levels in anti-IL-17-treated mice both with and without intact
Treg compartments, compared with isotype-control-treated animals
(Fig. 7C). In addition, neutrophil numbers in circulation were
reduced after IL-17 blockade in mice both with and without an intact
Treg compartment (Fig. 7D). We found that blockade of IL-17
reduced levels of IL-6, CXCL1, CXCL5 and G-CSF in arthritic paws
of mice with intact Treg compartments and tended to reduce IL-6 and
CXCL1 in mice depleted of Tregs (Fig. 7E). IL-17 blockade reduced
the levels of IL-6 and CXCL1 in mice that received Treg
depletion+anti-IL-17 to levels seen in non-Treg-depleted+isotype-
treated mice (Fig. 7E). Importantly, anti-IL-17 treatment reduced
levels of RANKL in paw tissue in mice both with and without intact
Treg compartments (Fig. 7F). In line with this, there was a tendency
towards a reduction of TRAP levels after IL-17 blockade. Treg
depletion reduced the RANKL/OPG ratio and IL-17 blockade
increased the RANKL/OPG ratio, indicating that Treg depletion
favours a more resorptive state, whereas IL-17 blockade reverses the
effect of Treg depletion on bone erosion (Fig. 7F). In summary, we
find that IL-17 blockade rescues mice from the increased disease
activity observed after Treg depletion, and does so through a reduction
in neutrophil numbers and local IL-6, CXCL1 and RANKL levels.
DISCUSSION
In RA, dysregulation of the Treg compartment has been reported,
and Treg numbers and levels of IL-17 expression correlate with
disease severity (Noack and Miossec, 2014; Zaiss et al., 2010).
Different approaches to tipping the Teff/Treg balance towards Treg
dominance have been put forward as potential therapeutic strategies
in RA and other inflammatory diseases; however, none have yet
been fully successful (Miyara et al., 2014). Knowledge of the roles
played by Tregs in experimental arthritis models is instrumental for
the development of safe and effective therapeutic strategies
involving Tregs in humans. In this study, we investigated the
kinetics of Tregs in DTHA and characterised the exacerbated
inflammatory response that resulted from selective depletion of
Tregs. To our knowledge, this is the first study to characterise the
mechanisms of exacerbated disease in an arthritis model following
depletion of Tregs using Foxp3-DTR-eGFP mice. Transient DT
treatment, although sufficient to give the desired biological effect
in many cases, can also leave a residual number of eGFP+ FoxP3+
cells, and these cells eventually repopulate the Treg niche (Lahl et al.,
2007; Lahl and Sparwasser, 2011). However, because we were
interested in examining the effects of Treg depletion on
inflammation in the early stages of DTHA, our assessment was
that this mouse was suitable for our purpose, despite its limitations.
Treg numbers in DTHA expanded rapidly and these cells were
found to be highly activated and proliferating in lymphoid and paw
tissue. This indicates that Tregs are important in the early stages of
DTHA. However, the fact that we observed severe inflammation in
the affected paw despite the expansion of Tregs could be the result of
a dysregulation of the Th17/Treg balance, because increased Th17
activity is also seen in the early stages of DTHA (Atkinson et al.,
2012). In support of this, we also show in the present study that
neutralisation of IL-17 reduced severity of disease and could prevent
the detrimental effects of Treg depletion in the model.
Selective Treg depletion increased arthritis severity, and the
observed correlation between paw inflammation and new bone
formation indicated that new bone formation could be linked to
inflammation in DTHA. In support of this, we have previously
Fig. 5. Treg depletion in DTHA has limited effect
on the overall composition of the microbiota in
the distal colon. Fecal microbiota was analysed
for bacterial 16S rRNA composition. (A) Alpha
diversity based on Shannon index of unfiltered data
for fecal samples. Median alpha diversity with
upper and lower quantiles shown, n=7. *P≤0.05.
(B) Beta diversity based on Whittaker’s species
turnover within each group. Median beta diversity
with upper and lower quantiles indicated, n=7.
(C) Taxa summary plot at phylum level showing
changes in the microbiota composition of the fecal
samples. Mean relative abundance shown, n=7.
(D) Taxa summary plot at phylum level showing
changes in the microbiota composition of the fecal
samples. Mean relative abundance shown, n=7.
Except for beta diversity, Wilcoxon rank-sum for
tests between groups andWilcoxon signed-rank for
tests within groups. This experiment was carried
out once.
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shown that suppression of inflammation in DTHA with anti-TNFα
antibodies (Atkinson et al., 2012) or anti-C5aR antibodies
(Atkinson et al., 2015) could reduce bone formation.
Inflammation has also been linked to bone formation in the CIA,
proteoglycan-induced arthritis (PGIA) and SKG inflammatory
arthritis models (Denninger et al., 2015; Schett et al., 2009;
Haynes et al., 2012; Keller et al., 2012), and in ankylosing
spondylitis (Maksymowych et al., 2013; Wanders et al., 2005).
However, Treg depletion also led to increased bone resorption in
DTHA in the present study. The presence of these two opposing
phenotypes can seem counterintuitive, but the bone formation and
bone erosion take place at different areas of the paw (Atkinson et al.,
2012), and simultaneous bone erosion and bone formation has also
been observed in the CIA model in a recent study (Denninger et al.,
2015). The net effect, however, is a negative association between
inflammation and bone mass, as previously described (Gilbert et al.,
2013; Proulx et al., 2007; Walsh et al., 2005).
Depletion of Tregs led to increased CD4
+ T-cell activation and to
increased recruitment of CD4+ T cells to the site of inflammation.
This shows that the control of Teff activation in the dPLN and Teff
numbers in the paw is one of the mechanisms of Treg-mediated
suppression of DTHA. We also observed increased levels of
anti-MCV, demonstrating an augmented immune response to a
citrullinated self-antigen. Anti-MCV antibodies and other anti-
citrullinated protein antibodies (ACPAs) are used as prognostic
biomarkers of disease and joint erosion in RA, and ACPA levels
correlate with serum CTX-I in RA patients (Gudmann et al., 2015;
Jilani and Mackworth-Young, 2015). The fact that we observe a
break of self-tolerance to MCV in DTHA and that anti-MCV levels
increase with increased disease severity adds to the strengths of
DTHA as amodel of RA. However, the current study did not address
which, if any, role anti-MCV plays in the pathogenesis of DTHA.
Previous studies have shown that Tregs are able to limit the
accumulation of Th17 cells at inflammatory sites and draining lymph
nodes (Lohr et al., 2006). Increased IL-17 productionwas observed in
the Treg-depleted mice in the present study. This is supported by the
observed increase in production of IL-6, IL-23 and IL-1β, which are
cytokines that favour Th17 polarisation (Lubberts et al., 2005;
Fig. 6. Depletion of Tregs augments production of inflammatory mediators locally in the affected paws. Whole paw homogenate supernatants were
analysed for protein levels (pg/g tissue) of a range of inflammatory markers using multiplex analysis. Mean±s.e.m. shown, n=10. Student’s t-test, *P≤0.05;
**P≤0.01; ***P≤0.001. P-values were corrected for mass significance using the False Discovery Rate method. The raw and corrected P-values are shown in
Table S1. MCP, monocyte chemoattractant protein; CCL, CC chemokine ligand; MIP, macrophage inflammatory protein; CXCL, CXC chemokine ligand; IP,
interferon gamma-induced protein; MIG, monokine induced by gamma interferon; RANTES, regulated on activation, normal T cell expressed and secreted;
G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor. Results presented in this figure are representative of
two independent experiments.
434


















Fig. 7. Treatment with anti-IL-17 rescues mice from exacerbated disease caused by Treg depletion. (A) Anti-IL-17 treatment was initiated at the time of
arthritis induction 1 day prior to Treg depletion and given every 48 h until experiment termination on day 7. Left graph: paw swelling day 0-7. Right graph: area
under curve (AUC) of paw swelling day 0-7. ns, not significant, *P≤0.05, ***P≤0.001. (B) Levels of anti-mutated-citrullinated-vimentin (MCV) antibodies in
serum measured by ELISA as optical density (OD). Dotted line represents levels in n=5 naïve mice. (C) Levels of myeloperoxidase (MPO) in paw tissue
measured by ELISA of whole paw homogenate supernatants. (D) Neutrophils/ml blood measured by flow cytometry. Neutrophils were defined as live
CD45+TCRβ−CD11b+Ly6G+ cells. ns, not significant, *P≤0.05. (E) Analysis of inflammatory mediators in whole paw homogenate supernatants from Treg-
depleted mice (blue bars) and non-depleted mice (black bars) treated with anti-IL-17 mAb or isotype control, using multiplex analysis [IL-1β, TNFα, IFNγ, IL-6,
IL-10, IL-12(p70), MIP-2 (CXCL2), IP-10 (CXCL10), LIX (CXCL5), RANTES (CCL5), MIG (CXCL9), MIP-1α (CCL3), KC (CXCL1), G-CSF and GM-CSF] and
ELISA (IL-23). Mean±s.e.m. shown, n=10. ns, not significant, *P≤0.05, Student’s t-test. P-values were corrected for mass significance using the False
Discovery Rate method. The raw and corrected P-values are shown in Table S1. This experiment was carried out once. (F) Levels of RANKL, OPG and TRAP
were measured in whole paw homogenate supernatants from Treg-depleted mice (blue) and non-depleted mice (black) treated with anti-IL-17 mAb or isotype
control, using ELISA. Mean±s.e.m. shown, n=10. ns, not significant, *P≤0.05. Dotted line represents mean OPG level in n=2 naïve mice. CCL, CC chemokine
ligand; MIP, macrophage inflammatory protein; CXCL, CXC chemokine ligand; IP, interferon gamma-induced protein; G-CSF, granulocyte colony-stimulating
factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; MIG, monokine induced by gamma interferon; OPG, osteoprotegerin; RANKL, receptor-
activator of nuclear factor κB ligand; RANTES, regulated on activation, normal T cell expressed and secreted; TRAP, tartrate-resistant acid phosphatase.
435


















Sonderegger et al., 2008; Sutton et al., 2006). IL-17 is an important
cytokine in experimental arthritis when T cells play a part in the
pathogenesis (Atkinson et al., 2012; Lubberts et al., 2005). Blockade
of IL-17 has previously been shown to ameliorate experimental
arthritis and is also a promising therapeutic avenue in RA (Lubberts
et al., 2001, 2004; Pöllinger et al., 2011; van den Berg and McInnes,
2013). We found that treatment with anti-IL-17 could attenuate
disease inDTHA, and the results indicate that IL-17 ismore important
for DTHA pathogenesis after the antigen challenge. The increased
IL-17 production after Treg depletion could also contribute to the
increased bone erosion observed, and results from other studies
support this. IL-17 induces osteoclastogenesis from human
monocytes in the absence of RANKL (Yago et al., 2009) and
upregulates RANKL expression (Gizinski and Fox, 2014), and
blocking IL-17 prevents joint destruction inCIA through an increased
RANKL/OPG ratio (Lubberts et al., 2004). Our results thus suggest
that the increase in bone erosion could be driven by an increase in the
RANKL/OPG ratio driven by increased IL-17 activity.
We observed increased IL-10 production in arthritic paws after
Treg depletion, which suggests that the contribution of IL-10 by Tregs
to immunoregulation in DTHA is negligible. In a study in which
Tregs were depleted using anti-CD25 mAb, we found that
concomitant blockade of IL-10 signalling increased paw and
ankle swelling to an even larger degree than Treg depletion or IL-10
blockade alone. In the absence of Tregs, regulatory B cells and their
release of IL-10 could represent a compensatory regulatory
pathway. B-cell-derived IL-10 has been shown to regulate
inflammation in other mouse models (Fillatreau et al., 2002;
Mauri et al., 2003; Mizoguchi et al., 1997). In experimental
autoimmune encephalitis (EAE), components fromMycobacterium
tuberculosis in the complete Freund’s adjuvant (CFA) that is used to
induce disease provide Toll-like receptor (TLR) agonists that can
trigger regulatory functions of B cells that are required for the
resolution of EAE (Lampropoulou et al., 2008).
Because B cells are not required for the induction of DTHA
(Tanaka et al., 2007) and because CFA containingM. tuberculosis is
also used for induction, it could be speculated that B cells indeed
play an immunoregulatory role in DTHA and that depletion of B
cells on top of Treg depletion would further exacerbate DTHA.
We also observed an increased number of neutrophils in paws,
dPLNs and blood as well as increased production of granulopoietic
factors and neutrophil chemoattractants after Treg depletion. This
could in part be driven by the increased IL-17 production, because
IL-17 is known to stimulate neutrophil recruitment through
induction of G-CSF, GM-CSF and chemoattractants, including
CXCL1 (Hamilton, 2008; Kolls and Lindén, 2004; Park et al., 2005;
Schwarzenberger et al., 2000). Increased levels of CXCL1 and
CXCL2 at the site of inflammation have also previously been shown
to result from Treg depletion in mice (Richards et al., 2010). Indeed,
blockade of IL-17 reduced neutrophil numbers in Treg-depleted
mice and reduced levels of CXCL1. IL-6 production can be induced
by IL-17 (Kolls and Lindén, 2004) and, in line with this, we
observed a major decrease of IL-6 production following IL-17
blockade. IL-6 plays an important role in neutrophil trafficking
(Fielding et al., 2008; Lally et al., 2005), so the observed decrease in
blood neutrophil numbers after IL-17 blockade could be a result of
the decreased IL-6 levels. Taken together, these data support a
regulatory role for IL-17 in neutrophil recruitment through IL-6 and
CXCL1.
Recent findings have suggested an association between the gut
microbiota and RA (Scher et al., 2013; Zhang et al., 2015), and
interactions between the gut microbiota and immune function,
including Tregs, neutrophils and IL-17, are well established
(Maynard et al., 2012). However, in our model, depletion of Tregs
did not significantly change the bacterial composition, indicating
that immune-driven changes in the gut microbiota are unlikely to
play an important role in disease progression in our model. We
observed a tendency towards higher alpha diversity in Treg-depleted
mice and that alpha diversity correlated inversely with ankle size at
day 4. Interestingly, we observed a tendency towards an increased
abundance of Lactobacillus on day 4, which also correlated with
maximal ankle swelling. Lactobacillus has been shown to be over-
represented in RA patients compared to healthy subjects (Liu et al.,
2013; Zhang et al., 2015), and the abundance of Lactobacillus was
also shown to correlate with disease activity in RA patients.
Furthermore, mono-colonisation with Lactobacillus bifidus was
shown to be sufficient for inducing joint inflammation in a mouse
model of spontaneous arthritis via TLR2- and TLR4-dependent
signalling affecting the balance between Treg, Th17 and Th1 in the
gut (Abdollahi-Roodsaz et al., 2008). When comparing the
microbial changes observed in laboratory animals to humans, it is
important to consider the marked environmental differences.
Moreover, in DTHA, severe disease is observed after just a few
days, whereas RA develops over several years. Although the
composition of the microbiota can change within days, the short
duration of the model might not be sufficient to markedly affect the
composition of the gut microbiota in a manner that reflects the
situation in human disease pathogenesis. Nevertheless, the findings
suggest a link between Lactobacillus and joint inflammation both in
rodent models and RA patients.
Conclusion
Taken together, our findings show that Tregs are important for the
containment of inflammation in DTHA, and that Treg depletion in
DTHA acts, at least partly, through increasing IL-17 and RANKL
activity and through increasing numbers of neutrophils in blood,
dPLNs and paws. We show that IL-17 drives an increase in
inflammation in the absence of Tregs: administration of anti-IL-17
mAb just prior to Treg depletion rescues mice from the exacerbation
of disease associated with Treg depletion through a reduction in IL-6
and CXCL1 production, reduced neutrophil numbers and a
reduction in the RANKL/OPG ratio. Thus, an imbalance in the
Treg and Th17 relationship could be a driver of inflammation in
DTHA. To our knowledge, this is the first study using the Foxp3-
DTR-eGFP mouse on a C57BL/6 (B6) background for Treg
depletion in an arthritis model, and we here demonstrate the
usefulness of the approach and build upon the already existing body
of work in this newmodel. Many genetically modifiedmice are bred
on a B6 background, and can thus be combined with the Foxp3-
DTR-eGFP C57BL/6 mouse, making possible the study of Treg
depletion in concert with the absence/overexpression of proteins
relevant for disease pathways. However, the limitations of the
Foxp3-DTR-eGFP mouse generated by BAC transgenesis must be
kept in mind when choosing this model system. Given the relevance
of Tregs in RA and the possibility of developing Treg-mediated
therapies for RA, using this approach for selective depletion of Tregs
could yield important results to help understand the diverse roles of
Tregs in RA and other inflammatory diseases.
MATERIALS AND METHODS
Mice
Female C57BL/6J mice were purchased from Taconic, Ry, Denmark.
Female Foxp3-DTR-eGFP mice were generated as described in Lahl
et al. (2007), and bred and maintained at Forschungseinrichtungen für
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Experimentelle Medizin, Charité Universitätsmedizin Berlin or purchased
from Jackson Laboratories (Bar Harbor, ME) on a NOD background
(generated as described in Feuerer et al., 2009) and backcrossed for at least
eight generations onto the C57BL/6 background at Taconic, Ry, Denmark.
Foxp3-DTR-eGFPmice express a fusion protein consisting of the diphtheria
toxin (DT) receptor (DTR) and enhanced green fluorescent protein (eGFP)
under the control of the Foxp3 gene locus inserted by BAC transgenesis.
This construct allows selective depletion of Tregs by DT injection. Animals
were housed in a facility with a 12-h light/dark cycle and with free access to
water and standard rodent chow (Altromin®). All animal experiments
performed in Germany were in accordance with the guideline 2010/63/EU
from the European Union and the European Convention for the protection
of vertebrate animals used for experimental and other scientific purposes.
Animal protocols were approved by the ethics committee and the Berlin
state authorities (LAGeSo registration # G0331/08). All animal experiments
performed in Denmark were conducted according to Danish legislation and
have been approved by the Danish Animal Inspectorate and the Novo
Nordisk ethical review board.
Induction and assessment of DTHA
Mice were anaesthetised by isoflurane/O2/N2O and immunised
intradermally (i.d.) with methylated bovine serum albumin (mBSA)
(Sigma, St Louis, MO) emulsified in complete Freund’s adjuvant (CFA)
(Difco, Detroit, MI) at the tail base. Four days later mice were given 1000 µg
(approx. 50 mg/kg body weight) anti-mouse type II collagen antibody (anti-
CII) cocktail (Chondrex, Redmond, WA) containing the clones A2-10
(IgG2a), F10-21 (IgG2a), D8-6 (IgG2a), D1-2G (IgG2b) and D2-112
(IgG2b) intravenously in 200 µl phosphate-buffered saline (PBS). Seven
days after immunisation the mice were challenged with 200 µg mBSA
subcutaneously in 20 μl PBS in the right foot pad. The left foot pad was
given 20 μl PBS only and served as control. Baseline paw and ankle
measurements were made on the right paw on day 0 prior to mBSA
challenge. Paw and ankle swelling was measured using a dial thickness
gauge (Mitutoyo, Japan), and was calculated as right paw or ankle thickness
minus baseline measurement.
Depletion of Tregs
Mice were injected intraperitoneally with 1 µg DT (Merck, Darmstadt,
Germany) in 100 µl PBS 24 and 48 h after DTHA induction. Depletion of
Tregs was confirmed by flow cytometry on whole blood sampled 24 h after
the final DT dose (Fig. S1 shows a representative depletion check). Cells
were gated on TCRβ, CD4 and CD25 and analysed for expression of eGFP.
Antibodies used were anti-CD16/32 (BD Biosciences, NJ) for blocking of
unspecific Fc-receptor binding, anti-TCRβ-PerCP-Cy5.5, clone H57-597
(eBioscience, San Diego, CA), anti-CD25-APC, clone PC61.5
(eBioscience, San Diego, CA), anti-CD4-PE-Cy7, clone RM4-5 (BD
Biosciences, NJ) or anti-CD4-Qdot605 (Invitrogen, Carlsbad, CA).
Depletion of Tregs and IL-10R blockade
For depletion of Tregs, mice were dosed with 200 µg rat anti-mouse CD25
mAb (clone PC.61, BioXcell, West Lebanon, NH) or rat IgG1 anti-
trinitrophenol (TNP) isotype control (Novo Nordisk A/S, Måløv, Denmark)
11 and 8 days prior to immunisation. For blockade of IL-10R, mice were
dosed with 250 µg rat anti-mouse IL-10R mAb (clone 1B1.3A, BioXcell,
West Lebanon, NH) or rat IgG1 anti-TNP isotype control (Novo Nordisk
A/S, Måløv, Denmark) three times weekly from the time of immunisation.
Depletion of Tregs was confirmed by flow cytometry on whole blood
samples drawn 48 h after the second dose of anti-CD25. Mouse regulatory T
cell staining kit (eBioscience, San Diego, CA) was used. Antibodies used
were CD45-PerCP, CD4-APC and CD25-FITC all from BD Biosciences
(NJ), and FoxP3-PE (eBioscience, San Diego, CA).
Anti-IL-17 mAb treatment
Mice were treated with 400 µg rat anti-mouse IL-17 mAb (clone 17F3,
BioXcell, West Lebanon, NH) or rat IgG1 isotype control (clone MOPC-21,
BioXcell, West Lebanon, NH) in 200 µl PBS on the day of arthritis
induction and with 200 µg rat anti-mouse IL-17 mAb or isotype control in
PBS after 48 h and every 48 h until the experiment was terminated on
day 7. For results presented in Fig. S4, mice were dosed with 200 µg rat anti-
mouse IL-17 mAb (clone 17F3, BioXcell, West Lebanon, NH) or rat IgG1
isotype control (clone MOPC-21, BioXcell, West Lebanon, NH) in 200 µl
PBS from the time of immunisation and every 48 h until study termination.
Histopathology
Paws were processed and stained with hematoxylin and eosin (H&E),
Safranin O and for tartrate-resistant acid phosphatase (TRAP) as previously
described (Atkinson et al., 2012). TRAP stains osteoclasts red, and Safranin
O stains cartilage red. The intensity of Safranin O staining is directly
proportional to the proteoglycan content in cartilage. Pathological changes
in the paws were assessed on H&E-, TRAP- and Safranin-O-stained
sections. The extra-articular infiltration of inflammatory cells (assessed on a
scale of 0-3) and arthritic changes were assessed separately. Arthritic
changes were assessed on metatarsal and tarsal joints as synovitis, cartilage
destruction and bone erosion, and scored separately on a 0-3 scale. For each
of the three parameters of arthritic changes, an average between the two joint
areas was calculated. In addition, new bone formation and extra-articular
infiltration overall in the pawwas scored on a 0-3 scale. New bone formation
was defined as the presence of osteophytes, as described in Atkinson et al.
(2012). The histology sum score was calculated by adding the five scores
(extra-articular infiltration, synovitis, cartilage destruction, bone erosion and
bone formation), whereas the extra-articular infiltration score is left out in
the arthritis score. The person who performed the evaluation was blinded to
the experimental setup.
Immunohistochemistry and digitalised image analysis
Immunohistochemical (IHC) detection of macrophages and neutrophils in
the paws was performed as previously described (Atkinson et al., 2015). The
sections were all digitally scanned and studied using a NanoZoomer Digital
Pathology Virtual Slide Viewer (Hamamatsu Photonic, Shizuoka, Japan).
Automated digital image analyses of the infiltrating macrophages (F4/80+)
and neutrophils (Ly6B.2+) in the paws were performed using the
Visiopharm Integrator System (VIS; version 4.2.2.0, Visiopharm,
Hoersholm, Denmark). On individual digital images of the arthritic paw a
region-of-interest (ROI) was automatically defined of the entire paw. The
bone marrowwas outlined manually and excluded from analysis, as was hair
follicles and artefacts. Next, an analysis was run inside the ROI to detect the
brown DAB (3-3′-diamino-benzidine-tetrahydrochloride) staining of the
target cells. The results are given as percentage of tissue area positive for F4/
80 or Ly6B.2 of the entire paw area.
Flow cytometry
Single-cell suspensions of blood, popliteal lymph nodes and paw infiltrate
were prepared as previously described (Atkinson et al., 2012). All samples
were subjected to Fc-blocking prior to antibody staining using anti-CD16/
32 (BD Biosciences, NJ). Dead cells were excluded using Fixable Near-IR
Vital dye (Invitrogen, Carlsbad, CA). Antibodies used were anti-CD45-
V500 (clone 30-F11, BD Biosciences, NJ), anti-CD45-eFluor450 (clone
30-F11, eBioscience, San Diego, CA), anti-TCRβ-PerCP-Cy5.5 (clone
H57-597, eBioscience, San Diego, CA), anti-TCRβ-Qdot655 (clone H57-
597, Molecular Probes, Carlsbad, CA) anti-CD4-PE-Cy7 (clone RM4-5,
BD Biosciences, NJ), anti-CD4-Qdot605 (clone RM4-5, Invitrogen,
Carlsbad, CA), anti-CD19-FITC (clone 1D3 eBioscience, San Diego,
CA), anti-CD62L-PE (clone MEL-14, eBioscience, San Diego, CA), anti-
CD44-APC (clone IM7, eBioscience, San Diego, CA), anti-CD8a-Pacific
Blue (clone 53-6.7, Biolegend, San Diego, CA), anti-F4/80-eFluor450
(clone BM8, eBioscience, San Diego, CA), anti-Ly6.G-PE (clone 1A8, BD
Biosciences, NJ) and anti-CD11b-APC (clone M1/70, eBioscience, San
Diego, CA). Samples were run on an LSRII or FACSCanto flow cytometer
and datawere analysed using FACSDiva software (BDBiosciences, NJ). All
cells were gated on live/dead marker and CD45 before further analysis.
Neutrophils were defined as CD11b+Ly6G+, macrophages as CD11b+F4/
80+, T cells as TCRβ+, and CD4 and CD8 T cells as TCRβ+CD4+ and
TCRβ+CD8+, respectively. Full gating strategies for the individual
experiments are shown in Fig. S1.
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Multiplex analysis of inflammatory markers in paw homogenate
Hind paws were sampled at selected times after DTHA induction and each
paw was placed in 1.25 ml of an ice-cold custom-made homogenization
buffer containing a solution of 200 mM NaCl, 5 mM EDTA, 10 mM Tris,
10% glycerin, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mg/ml
leupeptin and 28 mg/ml aprotinin with a pH value of 7.4 (Ampliqon,
Skovlunde, Denmark). The paws were homogenized by using a T25
Ultraturrax homogeniser (IKA, Staufen, Germany) followed by
centrifugation at 10,000 g for 15 min. The supernatants were decanted
and centrifuged once more at 10,000 g for 15 min. The final supernatants
were analysed undiluted for levels of IL-1β, TNFα, IFNγ, IL-6, IL-10, IL-
17, IL-12(p40), MIP-2 (CXCL2), IP-10 (CXCL10), LIX (CXCL5),
RANTES (CCL5), MIG (CXCL9), MIP-1α (CCL3), KC (CXCL1),
MCP-1 (CCL2), G-CSF and GM-CSF using bead-based Luminex®
xMAP® technology with Milliplex kits from Millipore (Billerica, MA)
according to the manufacturer’s instructions. For statistical analysis, any
values below the detection limit were set to the detection limit for the analyte
in question and any values above the detection limit were set to the upper
detection limit for the analyte in question.
Enzyme-linked immunosorbent assays (ELISAs)
Levels of serum amyloid P component (SAP) were measured in serum using
kits from Genway (San Diego, CA) according to the manufacturer’s
instructions. Levels of receptor-activator of nuclear factor kappa B
(RANKL), osteoprotegerin (OPG) and IL-23 were measured in paw
homogenate supernatants using kits from R&D Systems (Minneapolis, MN)
according to the manufacturer’s instructions. Levels of CTX-I and TRAP
were measured in serum and paw homogenate supernatants using ELISA
kits from Immunodiagnostic Systems (Boldon, UK) according to the
manufacturer’s instructions. Levels of MMP3, IL-6 and G-CSF were
measured in serum using kits from R&D Systems (Minneapolis, MN)
according to the manufacturer’s instructions. Antibodies to mutated
citrullinated vimentin (anti-MCV) were measured using kits from
Orgentec Diagnostika GmbH (Mainz, Germany) with the modification
that the detection antibody supplied in the kit was substituted with goat anti-
mouse IgG-HRP (Invitrogen, Carlsbad, CA) diluted 1:3000 and the
substrate solution supplied was substituted with substrate reagents from
R&D Systems (Minneapolis, MN).
mRNA deep sequencing
Arthritic hind paws were removed at the hairline and homogenised in
Qiagen RLT buffer (Qiagen, Germantown, MD) with 1% 2-
betamercaptoethanol (Sigma-Aldrich, St Louis, MO) and stored at
−80°C. The Ambion Magmax prep protocol was used to extract total
RNA. RNA quantity was assessed using the Nanodrop and RNA quality
was assessed using the Agilent Bioanalyzer (Agilent Technologies, Santa
Clara, CA). RNAseq libraries were prepared using the Illumina TruSeq
Sample Prep Kit (Illumina, Inc., San Diego, CA). 120 ng of total RNAwas
used for input. Barcode adapters were added to samples in such a way as to
allow pooling of samples in flow cell lanes in a randomized pattern relative
to sample annotation and source. Samples were sequenced using an Illumina
HiSeq 2000 (Illumina, Inc., San Diego, CA) at a multiplexing level
sufficient to generation 10-million to 25-million reads per sample.
Following generation of sequence, reads were aligned to the mouse
genome version NCBI m37 using TopHat (http://tophat.cbcb.umd.edu/).
Quality control of sequencing data was accomplished by using the
ShortRead package in R (http://www.r-project.org/). Aligned reads were
mapped to Ensembl transcript models and converted to reads per kilobase of
transcript per million mapped reads (RPKM) values using Cufflinks (http://
cufflinks.cbcb.umd.edu/).
Bacterial 16s rDNA sequencing
Bacterial DNA from fecal samples from the distal colon was extracted using
the NucleoSpin soil kit (Macherey-Nagel, Düren, Germany) following the
manufacturer’s protocol. Yield and integrity of the DNA were assessed by
Nanodrop and agarose gel electrophoresis, respectively. 16S rDNA
amplification and library generation were performed as previously
described (Holm et al., 2015). PCR products were purified using
Agencourt AMPure XP beads (Beckman Coulter, Brea, CA) and
normalized to 16-21 ng/μl per sample. Subsequently, samples were
pooled (5 μl of each sample) and quantified using a Qubit dsDNA HS
Assay Kit and a Qubit 2.0 Fluorometer (Life Technologies, Carlsbad, CA).
14 pM library and 0.7 pM PhiX Control v3 (Illumina, San Diego, CA) were
sequenced using an Illumina MiSeq V2 PE500 cartridge (500 cycles) on an
Illumina MiSeq. Sequences were analysed using QIIME v1.7.0 with default
settings including quality-based sequence trimming, removal of primers,
assembly of paired-end sequences and chimera checking (Caporaso et al.,
2010). De novo operational taxonomic unit (OTU)-picking was performed
by UCLUST (Edgar, 2010) utilizing 97% sequence similarity. OTUs were
assigned against the Greengenes database v11_2 (DeSantis et al., 2006)
using the RDP-classifier (Wang et al., 2007) with an 80% confidence
threshold. Analyses were performed in R v3.2.0 using the metagenomeSeq
(Paulson et al., 2013), PhyloSeq (McMurdie and Holmes, 2013) and Vegan
(Oksanen et al., 2011) packages. Data was filtered for low-abundant OTUs
by removing OTUs present in fewer than three of the 42 samples and with a
relative abundance across all samples ≤0.5%. Analyses on filtered data were
performed with an average of 20,731±7655 (s.d.) sequences per sample
compared to an initial 24,974±9382 (s.d.) sequences before filtering. Alpha
diversity (Shannon index) was calculated on unfiltered data. Read counts
were normalized using metagenomeSeq (Paulson et al., 2013), which
utilizes a cumulative-sum scaling where raw counts are divided by the
cumulative sum of counts up to a particular quantile. Principal coordinate
analysis (PCoA) using Bray-Curtis dissimilarity indices, analysis of
differential abundance of taxa and beta diversity analysis using
Whittaker’s species turnover were performed on filtered and normalized
data.
Statistics
Statistical analyses were conducted using GraphPad Prism software version
6.04. Non-parametric data or non-normal parametric data were analysed
using the Mann–Whitney U-test, and parametric data were analysed using a
two-sided unpaired Student’s t-test or one-way ANOVA. For statistical
analysis of the histology score data, a two-sided unpaired Student’s t-test
with Welch’s correction was used. For bacterial 16S rDNA, statistical
analyses were conducted using R differences in abundance of phyla, alpha
diversity measures and beta diversity between and within the FoxP3-DTR−
and FoxP3-DTR+ groups over the course of the study using the Wilcoxon
Rank-Sum and Wilcoxon Signed-Rank test, respectively, with Benjamini–
Hochberg P-value adjustment. Adonis test of significance was performed
using the calculated Bray–Curtis distance matrix, to test for overall
differences between the FoxP3-DTR− and FoxP3-DTR+ groups and
within each group over the course of the study. Correlation analyses
between taxonomic abundances, alpha diversity, serum markers, and paw
and ankle size were performed in R using Spearman’s rank correlation test
with Benjamini–Hochberg P-value adjustment. Differences between groups
and correlation coefficients were considered significant when P≤0.05
and levels of significance were assigned as *P≤0.05, **P≤0.01 and
***P≤0.001. In Figs 6 and 7E P-values were corrected for mass
significance using the False Discovery Rate method. The raw and
corrected P-values are shown in Table S1.
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